Cargando…
Expanding the scope of candidate prognostic marker IGFBP2 in glioblastoma
Glioblastoma is the most common malignant brain tumor in adults. Unfortunately, it has a very poor prognosis and no cure. In a recent paper by Yuan et al. (Bioscience Reports (2019), DOI:10.1042/BSR20190045) RNAscope was used to detect insulin-like growth factor binding protein 2 (IGFBP2) mRNA in gl...
Autor principal: | Lindström, Mikael S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639463/ https://www.ncbi.nlm.nih.gov/pubmed/31296788 http://dx.doi.org/10.1042/BSR20190770 |
Ejemplares similares
-
Comprehensive Analysis of Prognostic Value and Immune Infiltration of IGFBP Family Members in Glioblastoma
por: Zhong, Zhenglan, et al.
Publicado: (2022) -
Overexpression of IGFBP2 mRNA predicts poor survival in patients with glioblastoma
por: Yuan, Qing, et al.
Publicado: (2019) -
Simulation Predicts IGFBP2-HIF1α Interaction Drives Glioblastoma Growth
por: Lin, Ka Wai, et al.
Publicado: (2015) -
Expanding HTA – Correcting a Misattribution, Clarifying the Scope of HTA and CEA: Comment on "Ethics in HTA: Examining the ‘Need for Expansion’"
por: Culyer, Anthony J.
Publicado: (2019) -
Personalising cancer medicine with prognostic markers
por: Kerr, David J, et al.
Publicado: (2021)